Company registration number SC243125 (Scotland)
ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
COMPANY INFORMATION
Directors
MA Donn
JS Gordon
FD Laing
CR Richardson
(Appointed 1 July 2026)
Secretary
Resolis Limited
Company number
SC243125
Registered office
Exchange Tower
11th Floor
19 Canning Street
Edinburgh
Scotland
EH3 8EG
Auditor
Johnston Carmichael LLP
Strathlossie House
1 Kirkhill Avenue
Elgin
United Kingdom
IV30 8DE
ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
CONTENTS
Page
Directors' report
1 - 2
Directors' responsibilities statement
3
Independent auditor's report
4 - 7
Statement of income and retained earnings
8
Balance sheet
9
Statement of changes in equity
10
Notes to the financial statements
11 - 14
ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2026
- 1 -

The directors present their annual report and financial statements of Elgin Health (Easter Ross) Holdings Limited ("the company") for the year ended 31 March 2026.

Principal activities

The principal activity of the company continued to be that of a Holding Company to Elgin Health (Easter Ross) Limited.

Results and dividends

The profit for the financial year, after taxation, amounted to £206,291 (2025: £257,859).

The profit for the financial year will be transferred to reserves.

The directors are satisfied with the overall performance of the company and do not foresee any significant change in the company's activities in the coming financial year.

Ordinary dividends were paid amounting to £206,291 (2025: £257,859). As part of the March 2026 financial model submission cycle, the directors have approved a dividend of £261,816 to be paid in September 2026.

Key Performance Indicators

In its role as a holding company there are no key performance indicators for the directors to monitor. However, from a group point of view the performance of the investment is assessed every six months by testing the cash resources against the bank lending covenants. The key indicator being the debt service cover ratio. The investment has been compliant with the covenants laid out in the Group loan agreement.

Going Concern

Cash flow forecasts are prepared for the underlying investment looking over the expected life of the asset and so including the 12 month period from the date the financial statements are signed. In drawing up these forecasts, the directors have made assumptions based upon their view of the current and future economic conditions that will prevail over the forecast period. The Company's cash flows are dependent on the performance of its investment. After reviewing the performance of the investment, which is done on a regular basis, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. In light of this, the directors continue to adopt the going concern basis of accounting in preparing the Company’s annual financial statements.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

MA Donn
JS Gordon
FD Laing
PK Johnstone
(Retired 1 July 2026)
CR Richardson
(Appointed 1 July 2026)
Directors' insurance

The Company has made qualifying third party indemnity provisions for the benefit of its directors during the year. These provisions remain in force at the reporting date.

Auditor

The auditor, Johnston Carmichael LLP, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 2 -
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

Small companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
MA Donn
Director
30 July 2026
ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 MARCH 2026
- 3 -

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;

- make judgements and accounting estimates that are reasonable and prudent; and

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
- 4 -
Opinion

We have audited the financial statements of Elgin Health (Easter Ross) Holdings Limited (the 'company') for the year ended 31 March 2026 which comprise the statement of income and retained earnings, the balance sheet and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

- give a true and fair view of the state of the company's affairs as at 31 March 2026 and of its profit for the year then ended;

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

- have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report and financial statements other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report and financial statements. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

- the information given in the directors' r eport for the financial year for which the financial statements are prepared is consistent with the financial statements; and

- the directors' report has been prepared in accordance with applicable legal requirements.

ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED (CONTINUED)
- 5 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identifie d material misstatements in the directors' r eport. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

- the financial statements are not in agreement with the accounting records and returns; or

- certain disclosures of directors' remuneration specified by law are not made; or

- we have not received all the information and explanations we require for our audit; or

- the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption in preparing the directors' report and from the requirement to prepare a strategic report.

Responsibilities of Directors

As explained more fully in the directors' r esponsibilities s tatement set out on page 3, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Extent to which the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

We assessed whether the engagement team collectively had the appropriate competence and capabilities to identify or recognise non-compliance with laws and regulations by considering their experience, past performance and support available.

All engagement team members were briefed on relevant identified laws and regulations and potential fraud risks at the planning stage of the audit. Engagement team members were reminded to remain alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

We obtained an understanding of the legal and regulatory frameworks that are applicable to the Company and the sector in which it operates, focusing on those provisions that had a direct effect on the determination of material amounts and disclosures in the financial statements. The most relevant frameworks we identified include:

- Companies Act 2006;

- UK Tax legislation; and

- UK Generally Accepted Accounting Practice.

ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED (CONTINUED)
- 6 -
Extent to which the audit was considered capable of detecting irregularities, including fraud (continued)

We gained an understanding of how the Company is complying with these laws and regulations by making enquiries of management and those charged with governance. We corroborated these enquiries through our review of submitted returns and board meeting minutes.

We assessed the susceptibility of the Company’s financial statements to material misstatement, including how fraud might occur, by meeting with management and those charged with governance to understand where it was considered there was susceptibility to fraud. This evaluation also considered how management and those charged with governance were remunerated and whether this provided an incentive for fraudulent activity. We considered the overall control environment and how management and those charged with governance oversee the implementation and operation of controls. We identified a heightened fraud risk in relation to:

- Management override of controls

In addition to the above, the following procedures were performed to provide reasonable assurance that the financial statements were free of material fraud or error:

- Reviewing minutes of meetings of those charged with governance for reference to: breaches of laws and regulation or for any indication of any potential litigation and claims; and events or conditions that could indicate an incentive or pressure to commit fraud or provide an opportunity to commit fraud;

- Reviewing the level of and reasoning behind the Company’s procurement of legal and professional services;

- Performing audit work procedures over the risk of management override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business and reviewing judgements made by management in their calculation of accounting estimates for potential management bias;

- Completion of appropriate checklists and use of our experience to assess the company's compliance with the Companies Act 2006; and

- Agreement of the financial statement disclosures to supporting documentation.

Our audit procedures were designed to respond to the risk of material misstatements in the financial statements, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve intentional concealment, forgery, collusion, omission or misrepresentation. There are inherent limitations in the audit procedures performed and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it.

ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED (CONTINUED)
- 7 -

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Fiona Munro (Senior Statutory Auditor)
For and on behalf of Johnston Carmichael LLP
Statutory Auditor
Elgin, United Kingdom
30 July 2026
ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
STATEMENT OF INCOME AND RETAINED EARNINGS
FOR THE YEAR ENDED 31 MARCH 2026
- 8 -
2026
2025
Notes
£
£
Turnover
-
-
Income from shares in group undertakings
5
206,291
257,859
Interest receivable from group undertakings
5
113,660
113,660
Interest payable and similar expenses
6
(113,660)
(113,660)
Profit before taxation
206,291
257,859
Tax on profit
-
0
-
0
Profit for the financial year
206,291
257,859
Retained earnings brought forward
-
0
-
0
Dividends
7
(206,291)
(257,859)
Retained earnings carried forward
-
-

The profit and loss account has been prepared on the basis that all operations are continuing operations.

ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
BALANCE SHEET
AS AT 31 MARCH 2026
31 March 2026
- 9 -
2026
2025
Notes
£
£
£
£
Fixed assets
Investments
8
100,000
100,000
Current assets
Debtors falling due after more than one year
806,103
806,103
Net current assets
806,103
806,103
Total assets less current liabilities
906,103
906,103
Creditors: amounts falling due after more than one year
9
(806,103)
(806,103)
Net assets
100,000
100,000
Capital and reserves
Called up share capital
10
1,000
1,000
Share premium account
99,000
99,000
Total equity
100,000
100,000

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 30 July 2026 and are signed on its behalf by:
MA Donn
Director
Company registration number SC243125 (Scotland)
ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2026
- 10 -
Share capital
Share premium account
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 April 2024
1,000
99,000
-
0
100,000
Year ended 31 March 2025:
Profit and total comprehensive income
-
-
257,859
257,859
Dividends
7
-
-
(257,859)
(257,859)
Balance at 31 March 2025
1,000
99,000
-
0
100,000
Year ended 31 March 2026:
Profit and total comprehensive income
-
-
206,291
206,291
Dividends
7
-
-
(206,291)
(206,291)
Balance at 31 March 2026
1,000
99,000
-
0
100,000
ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
- 11 -
1
Accounting policies
Company information

Elgin Health (Easter Ross) Holdings Limited is a private company limited by shares incorporated in Scotland. The registered office is Exchange Tower, 11th Floor, 19 Canning Street, Edinburgh, Scotland, EH3 8EG.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared on a going concern basis, under the historical cost convention. The principal accounting policies adopted are set out below.

The entity has taken advantage of the option not to prepare consolidated financial statements contained in section 398 of the Companies Act 2006 on the basis that the entity and its subsidiary undertakings comprise a small group.

1.2
Going concern

Cash flow forecasts are prepared for the underlying investment looking over the expected life of the asset and so including the 12 month period from the date the financial statements are signed. In drawing up these forecasts, the directors have made assumptions based upon their view of the current and future economic conditions that will prevail over the forecast period. The Company's cash flows are dependent on the performance of its investment.true After reviewing the performance of the investment, which is done on a regular basis, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. In light of this, the directors continue to adopt the going concern basis of accounting in preparing the Company’s annual financial statements.

1.3
Fixed asset investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.

1.4
Financial instruments
Basic financial liabilities

Basic financial liabilities, including creditors and loans from fellow group companies are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 12 -
1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Impairment of assets

The carrying value of those assets recorded in the Company's Balance Sheet, at amortised cost, could be materially reduced where circumstances exist which might indicate that an asset has been impaired and an impairment review is performed. Impairment reviews consider the fair value and or value in use of the potentially impaired asset or assets and compares that with the carrying value of the asset or assets in the Balance Sheet. Any reduction in value arising from such a review would be recorded in the Statement of Comprehensive Income. Impairment reviews involve the significant use of assumptions. Consideration has to be given as to the price that could be obtained for the asset or assets, or in relation to a consideration of value in use, estimates of the future cash flows that could be generated by the potentially impaired asset or assets, together with a consideration of an appropriate discount rate to apply to those cash flows.

ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 13 -
3
Auditor's remuneration

The audit fee of £2,405 (2025: £2,315) was borne by the subsidiary company Elgin Health (Easter Ross) Limited. Auditor's remuneration is payable to Johnston Carmichael LLP.

4
Employees

The average monthly number of persons (including directors) employed by the company during the year was nil (2025: nil)

5
Interest receivable and similar income
2026
2025
£
£
Interest receivable and similar income includes the following:
Income from shares in group undertakings
206,291
257,859
Interest receivable from group companies
113,660
113,660
6
Interest payable and similar expenses
2026
2025
£
£
Interest on financial liabilities measured at amortised cost:
Interest payable to group undertakings
57,137
56,830
Subordinated debt interest payable
56,523
56,830
113,660
113,660
7
Dividends
2026
2025
2026
2025
Per share
Per share
Total
Total
Pence
Pence
£
£
Ordinary shares
Interim paid
206.29
257.86
206,291
257,859
8
Fixed asset investments
2026
2025
£
£
Shares in group undertakings and participating interests
100,000
100,000
ELGIN HEALTH (EASTER ROSS) HOLDINGS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 14 -
9
Creditors: amounts falling due after more than one year
2026
2025
£
£
Amounts owed to group undertakings
405,213
405,213
Other creditors
400,890
400,890
806,103
806,103

In May 2004 the Company borrowed £806,103 in Subordinated debt provided by Elgin Infrastructure Limited (50.3%) and Aberdeen Infrastructure Limited (49.7%). T he interest rate of the loan is 14.1% per annum with the capital element being repaid by a one-off payment in the year 2029. The Coupon on the principal accrues daily and is payable quarterly. The investment sum was advanced under a subordinated loan agreement and is therefore unsecured, and would rank alongside ordinary creditors in the case of a winding up.

10
Called up share capital
2026
2025
2026
2025
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 1p each
100,000
100,000
1,000
1,000
2026
2025
2026
2025
Preference share capital
Number
Number
£
£
Issued and fully paid
Share premium of 1p each
9,900,000
9,900,000
99,000
99,000
11
Financial commitments, guarantees and contingent liabilities

The company has granted a guarantee supported by a debenture incorporati ng fixed and floating charges over its assets and undertaking, in security of its wholly owned subsidiary's term loan from Bank of Scotland plc. Senior debt due to Bank of Scotland plc at the year end was £1,279,508 (2025: £1,945,969).

12
Related party transactions

During the year interest of £57,137 (2025: £56,830) was paid to Elgin Infrastructure Limited. During the year interest of £56,523 (2025: £56,830) was paid to Aberdeen Infrastructure Limited.

13
Parent company

The company is owned 50% by Elgin Infrastructure Limited, which is jointly owned between Cobalt Project Investment Limited and Ednaston Project Investments Limited, and 50% by Aberdeen Infrastructure (No.3) Limited. There is no ultimate controlling party.

2026-03-31 2025-04-01 false false false CCH Software CCH Accounts Production 2025.300 MA Donn JS Gordon FD Laing PK Johnstone CR Richardson Resolis Limited 0 SC243125 2025-04-01 2026-03-31 SC243125 bus:Director1 2025-04-01 2026-03-31 SC243125 bus:Director2 2025-04-01 2026-03-31 SC243125 bus:Director3 2025-04-01 2026-03-31 SC243125 bus:Director5 2025-04-01 2026-03-31 SC243125 bus:CompanySecretary1 2025-04-01 2026-03-31 SC243125 bus:Director4 2025-04-01 2026-03-31 SC243125 bus:RegisteredOffice 2025-04-01 2026-03-31 SC243125 2026-03-31 SC243125 2024-04-01 2025-03-31 SC243125 core:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 SC243125 core:RetainedEarningsAccumulatedLosses 2025-04-01 2026-03-31 SC243125 core:RetainedEarningsAccumulatedLosses 2025-03-31 SC243125 core:RetainedEarningsAccumulatedLosses 2024-03-31 SC243125 core:ShareCapital 2026-03-31 SC243125 core:ShareCapital 2025-03-31 SC243125 core:SharePremium 2026-03-31 SC243125 core:SharePremium 2025-03-31 SC243125 2025-03-31 SC243125 core:ShareCapital 2024-03-31 SC243125 core:SharePremium 2024-03-31 SC243125 core:RetainedEarningsAccumulatedLosses 2025-03-31 SC243125 core:RetainedEarningsAccumulatedLosses 2026-03-31 SC243125 core:ShareCapitalOrdinaryShareClass1 2026-03-31 SC243125 core:ShareCapitalOrdinaryShareClass1 2025-03-31 SC243125 core:ShareCapitalPreferenceShareClass1 2026-03-31 SC243125 core:Non-currentFinancialInstruments core:AfterOneYear 2026-03-31 SC243125 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 SC243125 core:Non-currentFinancialInstruments 2026-03-31 SC243125 core:Non-currentFinancialInstruments 2025-03-31 SC243125 bus:OrdinaryShareClass1 2025-04-01 2026-03-31 SC243125 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 SC243125 bus:PreferenceShareClass1 2025-04-01 2026-03-31 SC243125 bus:OrdinaryShareClass1 2026-03-31 SC243125 bus:OrdinaryShareClass1 2025-03-31 SC243125 bus:PreferenceShareClass1 2026-03-31 SC243125 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 SC243125 bus:FRS102 2025-04-01 2026-03-31 SC243125 bus:Audited 2025-04-01 2026-03-31 SC243125 bus:FullAccounts 2025-04-01 2026-03-31 xbrli:pure xbrli:shares iso4217:GBP